(44), intraneuronal calcium accumulation, and reactive astrocytosis ( lo), and improved
the energy state of the ischemic brain as indicated by the content of energy-rich phosphates
(63). The compound also reduced mortality following experimental brain ischemia
and improved neurologic symptoms (7,9,45,55). The effects, again, were independent
of route or time of administration.